Skip to content
Screener

Maze Therapeutics MAZE Market capitalization

Market capitalization at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$126.07B+9.0%
Septerna, Inc. logo
Septerna, Inc.SEPN
$1.51B+216%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$1.93B+436%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$1.3B+406%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$1.84B+147%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$6.28B+189%

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$48.0M-31.7%
Net income-$44.7M-32.8%
EPS (diluted)-$0.76+1.3%

Balance sheet

See full
Cash & equivalents$202.6M-23.4%
Total debt$60.4M+142%
Total equity$453.1M+72.8%
Total assets$531.6M+75.2%

Cash flow

See full
Operating cash flow-$15.1M+49.9%
CapEx$107.0K-72.8%
Free cash flow-$15.2M+50.2%

Valuation

See full
Enterprise value$1.37B+290%

Returns & leverage

See full
Return on equity-37.3%
Debt / equity0.1×0.0×
Current ratio18.3×+4.7×

Where this comes from

Computed from the period-end share price: $1.65B.

The source filing: Maze Therapeutics’s 10-Q, filed August 11, 2026. Open the filing →

Filed
Aug 11, 2026, 4:48 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-344903

FAQ

What is Maze Therapeutics's market capitalization?
Maze Therapeutics (MAZE) reported market capitalization of $1.65B in Q2 2026.
How has Maze Therapeutics's market capitalization changed year-over-year?
Maze Therapeutics's market capitalization increased by 265.0% year-over-year, from $452.42M to $1.65B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.

Ask your AI about Maze Therapeutics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude